AlphaQuest LLC trimmed its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 98.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 697 shares of the financial services provider’s stock after selling 36,498 shares during the quarter. AlphaQuest LLC’s holdings in MetLife were worth $57,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the business. Brighton Jones LLC increased its holdings in MetLife by 9.0% in the fourth quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock valued at $347,000 after purchasing an additional 351 shares during the period. Caxton Associates LLP acquired a new stake in shares of MetLife in the first quarter valued at about $307,000. Empowered Funds LLC raised its position in shares of MetLife by 187.6% during the first quarter. Empowered Funds LLC now owns 33,378 shares of the financial services provider’s stock worth $2,680,000 after acquiring an additional 21,771 shares during the last quarter. Sivia Capital Partners LLC acquired a new position in shares of MetLife in the second quarter worth approximately $404,000. Finally, MGO One Seven LLC increased its position in MetLife by 2.0% during the 2nd quarter. MGO One Seven LLC now owns 8,717 shares of the financial services provider’s stock valued at $701,000 after purchasing an additional 173 shares during the period. Institutional investors own 94.99% of the company’s stock.
MET opened at $77.26 on Friday. The firm has a 50-day moving average price of $78.92 and a 200-day moving average price of $78.80. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $87.39. The company has a quick ratio of 0.18, a current ratio of 0.20 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $50.91 billion, a price-to-earnings ratio of 16.44, a PEG ratio of 0.70 and a beta of 0.77.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Investors of record on Tuesday, February 3rd will be paid a dividend of $0.5675 per share. The ex-dividend date of this dividend is Tuesday, February 3rd. This represents a $2.27 annualized dividend and a yield of 2.9%. MetLife’s payout ratio is currently 48.30%.
A number of brokerages have recently issued reports on MET. Morgan Stanley set a $101.00 price target on shares of MetLife and gave the stock an “overweight” rating in a research report on Monday, December 15th. UBS Group boosted their target price on shares of MetLife from $94.00 to $98.00 and gave the company a “buy” rating in a report on Thursday, February 5th. Keefe, Bruyette & Woods decreased their price target on MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. Mizuho set a $100.00 price objective on MetLife in a research note on Thursday. Finally, Evercore set a $97.00 target price on MetLife and gave the stock an “in-line” rating in a research note on Tuesday, January 6th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.42.
Check Out Our Latest Analysis on MET
MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.
In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.
• Five stocks we like better than MetLife
• Your Bank Account Is No Longer Safe
• Buy this Gold Stock Before May 2026
• What a Former CIA Agent Knows About the Coming Collapse
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for MetLife and related companies with MarketBeat.com’s FREE daily email newsletter.…Read more by Defense World Staff